Here - American Geriatrics Society
Here - American Geriatrics Society
Here - American Geriatrics Society
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
P OSTER<br />
A BSTRACTS<br />
B61<br />
Losartan increases mitochondrial biogenesis in human fibroblast cells.<br />
V. Cheng, 2,1 B. Manwani, 1 J. Walston, 1 P. Abadir. 1 1. Johns Hopkins<br />
University, Baltimore, MD; 2. University of Kansas Medical Center,<br />
Kansas City, KS.<br />
Supported By: <strong>American</strong> Federation for Aging Research<br />
Mitochondrial function declines with age and is thought to influence<br />
chronic disease and frailty. The renin-angiotensin system (RAS)<br />
acts through angiotensin (Ang) II type 1 (AT 1<br />
R) and type 2 (AT 2<br />
R)<br />
receptors. We recently found a mitochondrial RAS, with AT 2<br />
R located<br />
in inner mitochondrial membranes that decrease with age and<br />
increase with AT 1<br />
R blocker losartan. Given these results, we hypothesized<br />
that the RAS plays a key role in mitochondrial biogenesis.<br />
Human fetal lung fibroblast cells (MRC-5) were grown in culture<br />
and separated into a control and treatment groups with serially<br />
increasing concentrations of losartan and Ang II. Cells given 100nM<br />
Ang II were subjected to losartan (0.01nM to 100nM). After 48 hrs,<br />
we measured mitochondrial gene ND6 and nuclear gene TK2 with<br />
qPCR. A ratio to compare gene expression based on treatment was<br />
generated.<br />
Mitochondrial biogenesis increased with higher doses of losartan.<br />
Cells given Ang II showed an increased ratio with Ang II up to<br />
1nM and decreased fold change above 1nM. Cells with Ang II and<br />
losartan displayed a reversal of AT 1<br />
R effects and increased mitochondrial<br />
biogenesis with losartan up to 10nM.<br />
These results illustrate a potentially important role of the RAS<br />
on mitochondrial biogenesis. While higher concentrations of losartan<br />
increase fold change, our results suggest a level of losartan that maximizes<br />
AT 1<br />
R blocking efficacy. Optimizing mitochondrial biogenesis<br />
via losartan is a novel approach that warrants further study in frail,<br />
older adults.<br />
ND6/TK2 ratio<br />
Cells with higher doses of losartan showed a higher ratio. Cells<br />
given Ang II show an increased ratio up to 1nM. Cells with 100nM<br />
Ang II and losartan showed an initial increase in ratio.<br />
B62<br />
The Hospital to Home Program: A Window into Healthcare<br />
Transitions for Older Adults.<br />
A. Cornell, J. Speice, T. Caprio, R. McCann. University of Rochester,<br />
Rochester, NY.<br />
Supported By: Reynolds Foundation<br />
HRSA GTPD Grant# HP08792<br />
BACKGROUND: Hospital readmission rates and levels of patient<br />
satisfaction have increasingly become a focus of attention as<br />
federal reimbursement policies change. Although a few programs<br />
have increased the efficiency of the discharge process, most hospitals<br />
lack sufficient resources to support a comprehensive discharge planning<br />
program outside the hospital. Data accumulated from the University<br />
of Rochester’s medical resident education program provides<br />
insight into the older adult patient’s perception of the discharge<br />
process.<br />
METHODS: A retrospective analysis from data collected from<br />
20 patients, age >60 years old, who participated in Highland Hospital’s<br />
“Hospital to Home Program” between September 2009 and September<br />
2011. This program focuses on training medical residents to<br />
identify discharge concerns during an inpatient bedside interview<br />
which is videotaped. Residents follow up with the patient one week<br />
after discharge in another videotaped encounter to gather information<br />
about the patient’s discharge experience. Video footage was reviewed<br />
by a clinical psychologist and the medical resident to identify<br />
common themes that contributed to negative discharge experiences.<br />
Learning points are highlighted in a video compilation that is presented<br />
to a group of medical residents during a teaching noon conference<br />
at the hospital to create a shared learning experience.<br />
RESULTS: Five main themes were identified from the patient<br />
feedback obtained during the program: difficulty accessing pain medicine<br />
or medical equipment, unclear discharge instructions, failure to<br />
have barriers to a safe return to home identified, inadequate follow<br />
up from home health nursing services, and difficulty obtaining answers<br />
to medical questions after discharge. One unique theme that<br />
was also identified was an expressed wish by some patients for more<br />
time to recover in the hospital due to preexisting caregiver responsibilities<br />
at home.<br />
CONCLUSION: The Hospital to Home program provides valuable<br />
insight into the problems that older adult patients experience<br />
after discharge from the hospital. Besides the educational value of this<br />
program, the identified themes provide distinct areas of focus for institutions<br />
striving to prevent unnecessary readmissions to the hospital.<br />
B63<br />
Enhancing Access to Palliative Care: An Initiative to Improve<br />
Advance Care Planning Documentation.<br />
A. Beyea, 1 H. Laura, 1,2 A. Caprio, 1,2 G. Winzelberg, 1,2 K. Wessell, 3<br />
C. Rowe. 4 1. Division of Geriatric Medicine and Center for Aging and<br />
Health, University of North Carolina, Chapel Hill, NC; 2. Palliative<br />
Care Program, The University of North Carolina, Chapel Hill, NC; 3.<br />
Cecil G. Sheps Center for Health Services Research, The University of<br />
North Carolina, Chapel Hill, NC; 4. Division of Hematology and<br />
Oncology, The University of North Carolina, Chapel Hill, NC.<br />
Purpose: This prospective study focused on improving documentation<br />
of advance care planning discussions for patients aged 65<br />
and older admitted to an Acute Care for the Elderly (ACE) unit at a<br />
university hospital. The primary aim was to increase utilization of an<br />
Advance Care Planning (ACP) note, a hospital-specific documentation<br />
tool in the electronic medical record (EMR).<br />
Methods: A case-based education session was repeated nine<br />
times from August 2010 to June 2011 to reach all physicians and medical<br />
students providing care to patients admitted to an ACE unit. Education<br />
covered communication and documentation about decisionmaking<br />
and preferences for life-sustaining treatments (LST).<br />
Following education sessions, participants received group performance<br />
data feedback. A gift card incentive was also used to encourage<br />
ACP discussions and documentation. Weekly chart review of patients<br />
discharged was used to collect data on outcomes: frequency of documented<br />
discussions about patient preferences for LST, and frequency<br />
of documentation with the ACP note tool.<br />
Results: Baseline chart review (N=88) showed 27% of patients<br />
had documentation of LST preferences, while only 4% were documented<br />
in the ACP note. Of the 204 charts reviewed during the intervention<br />
phase, 49% had documentation of LST preferences and 14%<br />
had an ACP note. For patients with dementia (N=64), 53% had documented<br />
discussion of LST preferences in the EMR; 41% in an ACP<br />
note. Among patients confused, sedated, or nonverbal (N=95), 56%<br />
had documented LST preferences in the EMR; 32% in an ACP note.<br />
Discussion: ACP note utilization facilitates effective communication<br />
about changes in health status and patient preferences for LST<br />
across a continuum of care. This quality improvement intervention<br />
was associated with an overall increase in frequency of ACP note utilization.<br />
Documentation practices among patients with dementia and<br />
confusion suggest that providers engage in discussions about LST<br />
preferences at least 50% of the time with patients at risk for progressive<br />
decline, adverse outcomes, and death.<br />
S94<br />
AGS 2012 ANNUAL MEETING